PBS Website Update - 1 April 2021

The Schedule of Pharmaceutical Benefits was updated on 1 April 2021 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website.

• Addendum to Schedule of Pharmaceutical Benefits
• Drugs subject to Price Disclosure - 1 April 2021
• Formulary Allocations - 1 April 2021
• Ex-manufacturer price - 1 April 2021
• First New Brand Price Reductions - 1 April 2021
• Items Exempt from Statutory Price Reductions - 1 April 2021
• General Statement for Drugs for the Treatment of Hepatitis C - 1 April 2021
• Medicine Status Website - 1 April 2021
• Stage 2 PBS Process Improvements – Resubmission Pathways Webinar Recording Available - 31 March 2021
• 2021 April Cycle – Brand Price Reductions and Savings to Patients - 31 March 2021
• Agenda for the July 2021 PBAC meeting - 31 March 2021
• Cost Recovery Fees and Charges - 31 March 2021
• AMWG Streamlined Pathways Subgroup - 30 March 2021
• PBAC Stakeholder Meetings - 26 March 2021
• Post-Market Review of medicines available on the PBS Opiate Dependence Treatment Program - 24 March 2021
• Active Ingredient Prescribing - 23 March 2021
• PBAC Public Summary Documents (first time rejections and deferrals) - November 2020 meeting - 19 March 2021
• Consultation: Critical Technologies for Australia – Agriculture & Health Sectors - 19 March 2021
• Drug Utilisation Sub-Committee (DUSC) Outcome Statement - 18 March 2021
• Drug Utilisation Sub-Committee (DUSC) Utilisation Analysis Public Release Documents - 18 March 2021
• Pharmaceutical Benefits Scheme Continued Dispensing Arrangements - 18 March 2021
• Health Products Portal Industry Webinars - 12 March 2021
• PBS Calendars - 12 March 2021
• Stage 2 PBS Process Improvements – Resubmission Pathways Webinar - 10 March 2021
• Price Disclosure Reductions for 2021 April Cycle - 2 March 2021